2023
Elizabeth R. Tucker et al.
Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Clinical Cancer Research 2023, vol. 29, issue 7
doi: 10.1158/1078-0432.ccr-22-2274
Pierre Romero et al.
EZH2mutations in follicular lymphoma distort H3K27me3 profiles and alter transcriptional responses to PRC2 inhibition
2023
doi: 10.1101/2023.01.02.522460